Outset Medical, Inc.
OMNasdaqCIK 1484612HealthcareFiscal year ends Dec 31
Reports and events: 103 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-01-0216:41 ET | 8-K | 2.03 New direct financial obligation | 0000950170-24-000306 |
| 2023-12-1116:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-23-069380 |
| 2023-11-0817:54 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060476 |
| 2023-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060250 |
| 2023-10-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-053108 |
| 2023-08-0318:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037387 |
| 2023-08-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037134 |
| 2023-07-0717:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-183869 |
| 2023-06-0116:06 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-025692 |
| 2023-05-0418:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017341 |
| 2023-05-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017186 |
| 2023-04-1316:06 ET | DEF 14A | Proxy statement | 0000950170-23-012706 |
| 2023-02-1317:19 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-002648 |
| 2023-02-1316:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-002612 |
| 2023-01-0908:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-000462 |
| 2022-11-0917:55 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023370 |
| 2022-11-0816:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023229 |
| 2022-11-0408:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-022068 |
| 2022-08-0216:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-013857 |
| 2022-08-0110:09 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-013586 |
| 2022-06-1316:16 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-011557 |
| 2022-06-0116:53 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-011033 |
| 2022-05-0518:21 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007473 |
| 2022-05-0416:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007400 |
| 2022-04-2516:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-006095 |
| 2022-04-1416:06 ET | DEF 14A | Proxy statementPeriod 2022-05-31 | 0001564590-22-014464 |
| 2022-02-2316:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-001769 |
| 2022-02-1616:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-001362 |
| 2021-11-0418:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-002879 |
| 2021-11-0316:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-002832 |
| 2021-08-0618:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-041765 |
| 2021-08-0516:16 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-041598 |
| 2021-07-0117:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-206486 |
| 2021-06-0416:00 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-031775 |
| 2021-05-2416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-029529 |
| 2021-05-0618:14 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-024269 |
| 2021-05-0516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-024014 |
| 2021-04-2116:05 ET | DEF 14A | Proxy statementPeriod 2021-06-03 | 0001564590-21-019807 |
| 2021-04-1316:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-114695 |
| 2021-04-0616:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-107658 |
| 2021-04-0616:13 ET | S-1 | Registration statement | 0001193125-21-107588 |
| 2021-03-2409:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-014981 |
| 2021-03-2216:01 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-014563 |
| 2021-03-0916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-011742 |
| 2021-02-2216:00 ET | 8-K | 8.01 Other events | 0001564590-21-007155 |
| 2021-01-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-001005 |
| 2020-11-3017:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-305714 |
| 2020-11-3017:01 ET | S-1 | Registration statement | 0001193125-20-305704 |
| 2020-11-1208:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-053315 |
| 2020-11-1207:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-053300 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:29 ET. Listed shows no prices and gives no investment advice.